Clinical Trials
3 trialsNCT03875820 2026-03-10
FRAME
Institute of Cancer Research, United Kingdom
Phase 1 Active not recruiting
NCT03681483 2024-07-10
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00773526 2016-11-02
A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.
Hoffmann-La Roche
Phase 1 Completed